Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-15-055198

Chief Executive Officer sold 5,200 shares at an average $54.72 ($284,545)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2015-06-17 Sale : show line 1 in the form −2,000 $54.86 $109,720 398,982 I
2015-06-17 Sale : show line 2 in the form −600 $55.60 $33,360 398,382 I
2015-06-18 Sale : show line 3 in the form −700 $52.62 $36,834 397,682 I
2015-06-18 Sale : show line 4 in the form −900 $53.83 $48,447 396,782 I
2015-06-18 Sale : show line 5 in the form −700 $55.77 $39,039 396,082 I
2015-06-18 Sale : show line 6 in the form −300 $57.15 $17,145 395,782 I
Open-market sales · 5,200 sh · avg $54.72 · $284,545
Loading xslF345X03/doc4.xml…